Lot No.: E-EL-R3030), catalase (Elabscience, USA
Retatrutide is currently being evaluated in Phase 3 clinical trials, which are the large-scale studies required to confirm efficacy and safety before a regulatory submission can be made
Lets get you one step closer to your health goals
For example, medical conditions were self-reported, whereas Bessette and Anderson were unable to measure all trial exclusion criteria with accurate temporality, which may underestimate the proportion excluded. Bessette said that primary care providers should consider screening for depression, liver function, and concomitant use of medications that delay gastric emptying before prescribing medications like GLP-1 receptor agonists
According to public FDA communications, the semaglutide drug shortage was officially resolved in February 2025, and tirzepatide was removed from the shortage list in October 2024